GlobeNewswire Inc.T3·27mo ago
GRF Eagle Capital Growth Fund, Inc.
XASEStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
GRF
—
—
Key stats
About
- Exchange
- XASE
- Market Cap
- $0.0B
- List Date
- 2007-10-15
- CIK
- 0000850027
- Homepage
- https://www.eaglecapitalgrowthfund.com
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock, giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.
Fund profile
- Expense ratio
- —
- Assets
- $38M shares × price, Oct 9, 2026
- Trailing yield
- —
- Average daily volume
- $39K 30 sessions
- Holdings
- —
- Listed
- Oct 15, 2007 NYSE American
Costn/a
Liquidity0
Scale22
Diversificationn/a
Similar funds
| Fund | Overlap | Fee | Assets | 1Y | |
|---|---|---|---|---|---|
| QQQInvesco QQQ Trust, Series 1 | — | 0.18% | $506.8B | +22.9% | compare |
| VUGVanguard Morningstar Growth ETF | — | 0.03% | $236.6B | +13.3% | compare |
| IWFiShares Russell 1000 Growth ETF | — | 0.18% | $130.5B | +7.7% | compare |
| QQQMInvesco NASDAQ 100 ETF | — | 0.15% | $111.6B | +22.9% | compare |
| IVWiShares S&P 500 Growth ETF | — | 0.18% | $80.3B | +19.1% | compare |
The largest other funds in the Large Cap Growth category.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -3.50% | 0.20% | 1.88% | -6.56% | -0.62% | -0.04% | -1.44% |
| Feb | -0.51% | -10.10% | -3.31% | 5.99% | -1.19% | -4.54% | -2.28% |
| Mar | 5.30% | 1.88% | -1.44% | -0.14% | -1.70% | -6.26% | -0.39% |
| Apr | 7.38% | 15.46% | 3.64% | -2.89% | 0.30% | -3.77% | 3.35% |
| May | 3.87% | -8.29% | -3.91% | 0.97% | -0.83% | -1.65% | -1.64% |
| Jun | -0.01% | -9.90% | 4.04% | -1.37% | -0.38% | 2.93% | -0.78% |
| Jul | -3.56% | -0.71% | 3.36% | 2.36% | 0.91% | -1.08% | 0.21% |
| Aug | 3.32% | -0.99% | -0.33% | 2.74% | 2.05% | -4.92% | 0.31% |
| Sep | 0.23% | 3.56% | -4.74% | 2.43% | 0.12% | -1.19% | 0.07% |
| Oct | 1.09% | 1.65% | -2.57% | 0.56% | 3.71% | -4.91%* | -0.08% |
| Nov | -10.45% | -1.51% | 0.83% | 5.16% | -8.16% | -- | -2.83% |
| Dec | 12.54% | -5.72% | 10.14% | -2.60% | 7.00% | -- | 4.27% |
| Total | 14.72% | -15.86% | 6.81% | 6.12% | 0.50% | -23.00% | -1.78% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $10.11
SMA 50: $10.29
SMA 200: $10.41
Current: $9.66
EMA 12: $9.97
EMA 26: $10.12
MACD: -0.1481 | Signal: -0.0476
BEARISH
ADX (14): 24.62
WEAK TREND
+DI: 20.99
−DI: 44.69
Momentum Oscillators
RSI (14): 37.00
NEUTRAL
Stoch %K: 26.60
Stoch %D: 34.00
Williams %R: -84.98
Volume & Volatility
BB Upper: $10.57
BB Lower: $9.65
NEUTRAL
OBV: -33,778
Vol SMA 20: 4,757
Vol ROC: 1131.90%
ATR: $0.21
True Range: $0.25
HV 20: 27.3%
HV 30: 31.9%
HV 60: 28.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-03-28T00:00:00 – 2026-10-09T00:00:00
AI Analysis
LLM Stock Analysis Report: GRF
Executive Summary
Overall Assessment: NEUTRAL with a confidence level of 6/10
Key Drivers:
- Recent FDA approval for Yimmugo immunoglobulin treatment
- Strong technical signals, including bullish MACD crossover and neutral RSI reading
- Low volatility and moderate volume trends
Primary Risks:
- High beta (-0.06) indicating potential for large price swings
- Negative correlation with the market, making it more sensitive to overall market sentiment
Investment Thesis: GRF presents a moderate risk opportunity with limited upside potential due to recent FDA approval. The stock's low volatility and neutral RSI reading suggest a possible consolidation phase before further significant movements.
Recent News Sentiment Impact: The recent news headlines have been generally positive, with a focus on regulatory approvals and business developments. However, the sentiment analysis is NEUTRAL due to the lack of surprise or market-moving information in the recent articles.
Technical Analysis
Trend Direction:
- Short-term: Neutral (1-4 weeks)
- Medium-term: Bullish (1-3 months)
- Long-term: Bullish (3-12 months)
Support/Resistance Levels: Upper Bollinger Band ($10.83) and SMA 20 ($10.43) serve as the primary resistance levels, while the Lower Bollinger Band ($10.03) and SMA 50 ($10.28) form the support levels.
Momentum Signals:
- RSI interpretation: Neutral (46.47), indicating a lack of overbought or oversold conditions
- MACD signal: Bullish, with a crossover above the signal line
- Bollinger Bands position: Neutral, as the price is trading between the upper and middle bands
Volume Analysis: The volume trends are moderate, with an On-Balance Volume (OBV) reading of -31256.99 indicating a slight bearish bias.
News & Sentiment Analysis
Recent Headlines Summary:
- Regulatory approvals for Yimmugo immunoglobulin treatment
- Business developments, including partnerships and alliances
Sentiment Assessment: NEUTRAL sentiment due to the lack of surprise or market-moving information in the recent articles.
Catalyst Identification: None identified from the recent news headlines.
Market Narrative: The technical signals are generally bullish, with a focus on momentum indicators. The neutral RSI reading and moderate volume trends suggest a possible consolidation phase before further significant movements.
Risk & Volatility Assessment
Risk Metrics:
- Beta: -0.06 (vs SPY)
- Alpha: 0.03
- Correlation: -0.03
- Stock Volatility: 0.33
Interpretation: The negative beta indicates that the stock moves opposite to the market, making it more sensitive to overall market sentiment.
Downside Protection: Support levels include SMA 50 ($10.28) and SMA 200 ($10.45), while resistance levels are at SMA 20 ($10.43) and Upper Bollinger Band ($10.83).
Market Context & Positioning
Sector Performance:
- GRF is trading in line with its sector (Healthcare)
Institutional Activity: Moderate institutional interest, with a volume rate of change of -42.13%.
Correlation Analysis:
- R-squared interpretation: 0.45, indicating a moderate positive correlation between GRF and the market.
Relative Valuation: GRF is trading within its historical range, with a relative strength index (RSI) reading of 46.47.
Key Levels & Action Items
Critical Price Levels:
- Support: SMA 50 ($10.28), SMA 200 ($10.45)
- Resistance: Upper Bollinger Band ($10.83), SMA 20 ($10.43)
Breakout/Breakdown Levels:
- SMA 20 ($10.43) - a potential breakout level
- Lower Bollinger Band ($10.03) - a potential breakdown level
Time-Sensitive Catalysts: None identified from the recent news headlines.
Risk Management: Stop-loss levels should be set at SMA 50 ($10.28) to limit potential losses, with position sizing considerations based on the stock's volatility (0.33).
Generated
News
All GRF news →
GlobeNewswire Inc.T3·28mo ago
GlobeNewswire Inc.T3·28mo ago
GlobeNewswire Inc.T3·30mo ago
GlobeNewswire Inc.T3·30mo ago
GlobeNewswire Inc.T3·30mo ago
GlobeNewswire Inc.T3·30mo ago
GlobeNewswire Inc.T3·30mo ago
GlobeNewswire Inc.T3·30mo ago
MarketWatchT3·31mo ago
Showing 1–10 of 16
Page 1 of 2
GRF Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: -0.0821
Alpha: -3.21%
Correlation: -0.0320
R-Squared: 0.1%
Stock Volatility: 34.1%
Market Volatility: 13.3%
Analysis Details
Benchmark: SPY
Data Points: 193
Period: 252 trading days
Data Points: 193
Period: 252 trading days
Interpretation:
Negative beta - stock moves opposite to market
Negative beta - stock moves opposite to market
Beta & Alpha Over Time
GRF Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
GRF Insider Trading (Form 4)
Latest: 2026-09-03Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Luke E Sims | President & CEO | Buy (P) | +2,560 | $9.99 | $25.6K | EDGAR |
| 2026-05-27 | David C Sims | CFO, CCO, Secretary, Treasurer | Buy (P) | +10,000 | $10.00 | $100.0K | EDGAR |
| 2026-05-19 | Luke E Sims | President & CEO | Mixed | +1,467 | $10.18 | $14.9K | EDGAR |
| 2026-05-13 | Donald G Tyler | Director | Mixed | +1,886 | $10.05 | $19.0K | EDGAR |
| 2026-05-05 | Donald G Tyler | Director | Mixed | +1,023 | $9.91 | $10.1K | EDGAR |
| 2026-02-12 | Neal F. Zalenko | Director | Buy (P) | +2,400 | $11.05 | $26.5K | EDGAR |
| 2026-02-04 | Neal F. Zalenko | Director | Mixed | +1,088 | $10.80 | $11.8K | EDGAR |
| 2026-01-14 | Neal F. Zalenko | Director | Mixed | +1,266 | $10.83 | $13.7K | EDGAR |
| 2025-12-03 | Neal F. Zalenko | Director | Buy (P) | +1,025 | $10.00 | $10.2K | EDGAR |
| 2025-11-28 | Neal F. Zalenko | Director | Buy (P) | +1,000 | $10.13 | $10.1K | EDGAR |
| 2025-11-19 | Neal F. Zalenko | Director | Buy (P) | +1,511 | $10.75 | $16.2K | EDGAR |
| 2025-11-12 | Neal F. Zalenko | Director | Buy (P) | +1,000 | $10.65 | $10.7K | EDGAR |
| 2025-10-21 | Luke E Sims | President & CEO | Mixed | +2,975 | $10.54 | $31.4K | EDGAR |
| 2025-10-17 | David C Sims | CFO, CCO, Secretary, Treasurer | Mixed | +10,135 | $10.59 | $107.4K | EDGAR |
| 2025-07-25 | Donald G Tyler | Director | Sell (S) | −3,240 | $10.02 | -$32.5K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
GRF Insider Holdings
5 insiders · @ $9.66
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Luke E Sims | President & CEO | 309,216 | $2.99M | -$1.94M | 65 | 2026-09-03 |
| 2 | David C Sims | CFO, CCO, Secretary, Treasurer | 247,932 | $2.40M | $1.69M | 52 | 2026-05-27 |
| 3 | Neal F. Zalenko | Director | 22,616 | $218.5K | $145.5K | 9 | 2026-02-12 |
| 4 | Donald G Tyler | Director | 9,945 | $96.1K | $5.3K | 9 | 2026-05-13 |
| 5 | Robert M Bilkie | Director | 2,364 | $22.8K | $21.7K | 3 | 2025-02-14 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
13 ETFs hold GRF
13 shown · $141.47M total exposure · 0.01% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXUS Vanguard Total International Stock ETF | Vanguard | 0.01% | $48.1M | — | 2026-08-31 |
| 2 | VEA Vanguard FTSE Developed Markets ETF | Vanguard | 0.01% | $32.1M | — | 2026-08-31 |
| 3 | IEFA iShares Core MSCI EAFE ETF | iShares (BlackRock) | 0.01% | $22.5M | $189.5B | 2026-10-08 |
| 4 | SCZ iShares MSCI EAFE Small-Cap ETF | iShares (BlackRock) | 0.08% | $9.9M | $12.9B | 2026-10-08 |
| 5 | VGK Vanguard FTSE Europe ETF | Vanguard | 0.02% | $7.9M | — | 2026-08-31 |
| 6 | VEU Vanguard FTSE All-World Ex-US ETF | Vanguard | 0.01% | $7.8M | — | 2026-08-31 |
| 7 | IXUS iShares Core MSCI Total International Stock ETF | iShares (BlackRock) | 0.01% | $4.1M | $58.6B | 2026-10-08 |
| 8 | IDEV iShares Core MSCI International Developed Markets ETF | iShares (BlackRock) | 0.01% | $3.7M | $33.1B | 2026-10-08 |
| 9 | VT Vanguard Total World Stock ETF | Vanguard | 0.00% | $2.6M | — | 2026-08-31 |
| 10 | IEUR iShares Core MSCI Europe ETF | iShares (BlackRock) | 0.02% | $1.9M | $9.2B | 2026-10-08 |
| 11 | ISCF iShares International Small-Cap Equity Factor ETF | iShares (BlackRock) | 0.07% | $478,545 | $660.2M | 2026-10-08 |
| 12 | IEUS iShares MSCI Europe Small-Cap ETF | iShares (BlackRock) | 0.18% | $294,074 | $163.2M | 2026-10-08 |
| 13 | SPEU State Street® SPDR® Portfolio Europe ETF | SPDR (State Street) | 0.02% | $144,489 | $683.4M | 2026-10-08 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.